Search results
Showing 3256 to 3270 of 8975 results
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Families and relationships settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios {"@context":"http://schema.org","@type":"BreadcrumbList"
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Families and relationships settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Services for older people {"@context":"http://schema.org"
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services {"@context":"http://schema.org"
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios {"@context":"http://schema.org","@type":"BreadcrumbList"
Interim methods guide for developing good practice guidance (PMG15)
This interim methods guide is based on the general principles and methods included in other methods guides for developing NICE guidance
Interim clinical guideline surveillance process and methods guide 2013 (PMG16)
This guide outlines the main elements of the interim NICE clinical guideline surveillance process and methodology, which was agreed by the NICE Board in July 2013
This guide outlines the main elements of the interim process and methods for the NICE clinical guideline updates using standing committees pilot programme, including details of the Clinical Guidelines Updates committee, which were agreed by the NICE Board in September 2013
This document concerns the appeal process for the technology appraisal and highly specialised technologies programmes and provides an overview for organisations wishing to lodge an appeal
This document is one of a series describing the processes and methods that NICE uses to carry out technology appraisals. It focuses on the technology appraisal processes
Evidence summaries: unlicensed and off-label medicines – Interim process statement (PMG2)
This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs
This document contains advice to help you access treatments and care that NICE has recommended
Healthy start vitamins: special report on cost effectiveness (ECD5)
This document describes a special report on the cost effectiveness of moving the Healthy Start vitamin programme from the current targeted offering to a universal offering
This document summarises the most common accessibility changes NICE is making in guidelines, and why